Guardant

Guardant Health Issues Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Guardant Health a leading precision oncology company headquartered in Palo Alto, California, has announced the approval and issuance of a significant equity-based inducement compensation package for newly hired employees. The…

Read MoreGuardant Health Issues Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
HCA-Healthcare-

HCA Healthcare Employees Contribute Over 41,800 Volunteer Hours During Annual Days of Service

HCA Healthcare Strengthens Community Impact Through Annual Volunteer Initiative HCA Healthcare, one of the leading healthcare providers in the United States, has announced the successful completion of its seventh annual “We Show Up for Our Communities” volunteer initiative, highlighting the…

Read MoreHCA Healthcare Employees Contribute Over 41,800 Volunteer Hours During Annual Days of Service
Superior

Superior HealthPlan Distributes $100,000 in Grants to 10 Texas Community Organizations

Superior HealthPlan Awards $100,000 in Grants to Support Community Health Initiatives Across Texas Superior HealthPlan, one of Texas’ leading managed care organizations and a subsidiary of Centene Corporation, has announced the recipients of its 2026 annual community grant program, awarding…

Read MoreSuperior HealthPlan Distributes $100,000 in Grants to 10 Texas Community Organizations
Aspera

Aspera Biomedicines Launches Second ADAR1p150 Crystallization Study to ISS on SpaceX CRS-34

Aspera Biomedicines Successfully Launches Second ADAR1p150 Protein Crystallization Experiment to the International Space Station Aboard SpaceX CRS-34 Aspera Biomedicines Inc., a biotechnology company focused on developing first-in-class therapies targeting cancer stem cells, has successfully launched its second ADAR1p150 protein crystallization…

Read MoreAspera Biomedicines Launches Second ADAR1p150 Crystallization Study to ISS on SpaceX CRS-34
Savara

Savara Reports New Exercise Capacity Results from IMPALA-2 Phase 3 Trial of Molgramostim in aPAP

Savara Presents New Exercise Capacity Data from IMPALA-2 Phase 3 Trial of Molgramostim in aPAP at ATS 2026 International Conference Savara a clinical-stage biopharmaceutical company focused on developing therapies for rare respiratory diseases, announced new clinical findings from its IMPALA-2…

Read MoreSavara Reports New Exercise Capacity Results from IMPALA-2 Phase 3 Trial of Molgramostim in aPAP
KORU

KORU Medical Systems Showcases Real-World Data Supporting FreedomEDGE Syringe Infusion System at ONS Congress

KORU Medical Systems Presents Real-World Evidence on FreedomEDGE® Syringe Infusion System at 51st Oncology Nursing Society Congress KORU Medical Systems,a leading medical technology company specializing in innovative and patient-centered large-volume subcutaneous infusion solutions, announced that it recently presented new real-world…

Read MoreKORU Medical Systems Showcases Real-World Data Supporting FreedomEDGE Syringe Infusion System at ONS Congress
Vir

Vir Biotechnology Announces Presentation of Complete Week 96 SOLSTICE Hepatitis Delta Data at EASL 2026

Vir Biotechnology to Showcase Full 96-Week Phase 2 SOLSTICE Hepatitis Delta Trial Results at European Association for the Study of the Liver Congress 2026 Vir Biotechnology announced that new clinical data from its Phase 2 SOLSTICE trial evaluating the investigational…

Read MoreVir Biotechnology Announces Presentation of Complete Week 96 SOLSTICE Hepatitis Delta Data at EASL 2026